1
|
Abdelmissih S, Sayed WM, Rashed LA, Kamel MM, Eshra MA, Attallah MI, El-Naggar RAR. The extent of involvement of ouabain, hippocampal expression of Na+/K+-ATPase, and corticosterone/melatonin receptors ratio in modifying stress-induced behavior differs according to the stressor in context. Braz J Med Biol Res 2022; 55:e11938. [PMID: 35857994 PMCID: PMC9296128 DOI: 10.1590/1414-431x2022e11938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2021] [Accepted: 04/18/2022] [Indexed: 11/21/2022] Open
Abstract
The aim of this study was to assess the effect of two types of stressors,
regarding the extent of involvement of ouabain (OUA), hippocampal
sodium/potassium ATPase (NKA) expression, and the hippocampal
corticosterone receptors (CR)/melatonin receptors
(MR) expression ratio, on the behavioral and cardiovascular
responses and on the hippocampal cornu ammonis zone 3 (CA3) and dentate gyrus
(DG). Thirty adult male Wistar albino rats aged 7-8 months were exposed to
either chronic immobilization or a disturbed dark/light cycle and treated with
either ouabain or vehicle. In the immobilized group, in the absence of
hippocampal corticosterone (CORT) changes, rats were non-responsive to stress,
despite experiencing increased pulse rate, downregulated hippocampal
sodium/potassium pump, and enhanced hippocampal CR/MR
expression ratio. Prolonged darkness precipitated a reduced upright attack
posture, with elevated CORT against hippocampal MR
downregulation. Both immobilization and, to a lesser extent, prolonged darkness
stress resulted in histopathological and ultrastructural neurodegenerative
changes in the hippocampus. OUA administration did not change the behavioral
resilience in restrained rats, despite persistence of the underlying biochemical
derangements, added to decreased CORT. On the contrary, with exposure to short
photoperiods, OUA reverted the behavior towards a combative reduction of
inactivity, with unvaried CR/MR and CORT, while ameliorating
hippocampal neuro-regeneration, with co-existing NKA and
MR repressions. Therefore, the extent of OUA, hippocampal
NKA expression, and CR/MR expression, and
subsequent behavioral and cardiac responses and hippocampal histopathology,
differ according to the type of stressor, whether immobilization or prolonged
darkness.
Collapse
Affiliation(s)
- S Abdelmissih
- Department of Medical Pharmacology, Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo, Egypt
| | - W M Sayed
- Department of Anatomy and Embryology, Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo, Egypt
| | - L A Rashed
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo, Egypt
| | - M M Kamel
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo, Egypt.,Department of Basic Medical Science, Faculty of Medicine, King Salman International University, South Sinai, Egypt
| | - M A Eshra
- Department of Physiology, Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo, Egypt
| | - M I Attallah
- Department of Medical Pharmacology, Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo, Egypt
| | - R A-R El-Naggar
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Misr University for Science and Technology, Giza, Egypt
| |
Collapse
|
2
|
Khajah MA, Mathew PM, Luqmani YA. Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells. PLoS One 2018; 13:e0193779. [PMID: 29590154 PMCID: PMC5874017 DOI: 10.1371/journal.pone.0193779] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2017] [Accepted: 02/17/2018] [Indexed: 01/27/2023] Open
Abstract
Background The Na+/K+-ATPase (NKP) is an important ion transporter also involved in signal transduction. Its expression profile is altered in various tumours including that of the breast. We studied the effect of inhibiting NKP activity in non-tumorigenic breast cell line and in estrogen receptor positive and negative breast cancer cells. Methods Expression and localization of NKP and downstream signaling molecules were determined by RT-PCR, western blotting and immunofluorescence. Cell proliferation, apoptosis and cell cycle stage were determined using MTT, annexin V and flow cytometry. Cell motility and invasion were determined using wound healing and matrigel assays. Total matrix metalloproteinase (MMP) was determined by a fluorescence-based assay. Results NKP was mainly localized on the cell membrane. Its baseline expression and activity were enhanced in breast cancer compared to the non-tumorigenic breast cell line. Ouabain and 3,4,5,6-tetrahydroxyxanthone (TTX) treatment significantly inhibited NKP activity, which significantly reduced cell proliferation, motility, invasion and pH-induced membrane blebbing. EGF stimulation induced internalization of NKP from the cell membrane to the cytoplasm. Ouabain inhibited EGF-induced phosphorylation of Rac/cdc42, profillin, ERK1/2 and P70S6K. Conclusions The NKP may offer a novel therapeutic target in breast cancer patients who have developed metastasis, aiming to improve therapeutic outcomes and enhance survival rate.
Collapse
|
3
|
Gould HJ, Norleans J, Ward TD, Reid C, Paul D. Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumps. Oncotarget 2018; 9:15606-15615. [PMID: 29643996 PMCID: PMC5884651 DOI: 10.18632/oncotarget.24581] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2017] [Accepted: 02/21/2018] [Indexed: 01/23/2023] Open
Abstract
Sodium influx through voltage-gated sodium channels (VGSCs) coupled with balanced removal of sodium ions via Na+, K+-ATPase is a major determinant of cellular homeostasis and intracellular ionic concentration. Interestingly, many metastatic carcinomas express high levels of these channels. We hypothesized that if excess VGSCs are activated and Na+, K+-ATPase is simultaneously blocked, the intracellular Na+ concentration should increase, resulting in water movement into the cell, causing swelling and lytic cell death. MDA-MB-231 breast cancer cells over-express VGSCs by 7-fold. To test our hypothesis, we treated these cells in vitro with the Na+, K+-ATPase blocker, ouabain, and then stimulated with a sublethal electric current. For in vivo histologic and survival studies, MDA-MB-231 xenografts were established in Nu/J mice. Mice injected with saline or ouabain were electrically stimulated with trains of 10 msec 10V DC pulses. Within seconds to minutes, the cells swelled and lysed. MCF-10a cells, which express normal VGSCs levels, were unaffected by this treatment. Cells from the weakly-malignant cell line, MCF-7, which express 3-fold greater VGSCs than MCF-10a cells, displayed an intermediate time-to-lysis. The rate of lysis correlated directly with the degree of sodium channel expression and malignancy. We also demonstrated efficacy in cell lines from prostate, colon and lung carcinomas. Treated MDA-MB-231 xenografts showed 60-80% cell death. In survival studies, TOL-treated mice showed significantly slower tumor growth vs. controls. These results are evidence that this "targeted osmotic lysis" represents a novel method for selectively killing cancer cells and warrants further investigation as a potential treatment for advanced and end-stage breast cancer.
Collapse
Affiliation(s)
- Harry J Gould
- Department of Neurology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Center of Excellence for Oral and Craniofacial Biology, Louisiana State University Health Sciences Center, New Orleans, LA, USA
| | - Jack Norleans
- Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA, USA
| | - T David Ward
- Department of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, LA, USA
| | - Chasiti Reid
- Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA, USA
| | - Dennis Paul
- Department of Neurology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA.,Center of Excellence for Oral and Craniofacial Biology, Louisiana State University Health Sciences Center, New Orleans, LA, USA
| |
Collapse
|
4
|
Affiliation(s)
- John M Hamlyn
- From the Departments of Physiology (J.M.H., M.P.B.) and Medicine (M.P.B.), University of Maryland School of Medicine, Baltimore.
| | - Mordecai P Blaustein
- From the Departments of Physiology (J.M.H., M.P.B.) and Medicine (M.P.B.), University of Maryland School of Medicine, Baltimore.
| |
Collapse
|